Canada markets closed

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
131.38-1.36 (-1.02%)
At close: 04:00PM EDT
130.00 -1.38 (-1.05%)
After hours: 07:56PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 12.42B
Enterprise Value 12.41B
Trailing P/E 305.53
Forward P/E 30.96
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.91
Price/Book (mrq)12.92
Enterprise Value/Revenue 8.84
Enterprise Value/EBITDA 129.58

Trading Information

Stock Price History

Beta (5Y Monthly) 0.94
52-Week Change 3-11.87%
S&P500 52-Week Change 326.49%
52 Week High 3152.21
52 Week Low 355.25
50-Day Moving Average 3126.40
200-Day Moving Average 3113.56

Share Statistics

Avg Vol (3 month) 3898.1k
Avg Vol (10 day) 31.09M
Shares Outstanding 594.52M
Implied Shares Outstanding 694.52M
Float 890.32M
% Held by Insiders 14.41%
% Held by Institutions 188.73%
Shares Short (Apr 30, 2024) 45.69M
Short Ratio (Apr 30, 2024) 47.33
Short % of Float (Apr 30, 2024) 46.30%
Short % of Shares Outstanding (Apr 30, 2024) 46.02%
Shares Short (prior month Mar 28, 2024) 44.6M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 12, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 1.20%
Operating Margin (ttm)8.44%

Management Effectiveness

Return on Assets (ttm)-1.89%
Return on Equity (ttm)2.02%

Income Statement

Revenue (ttm)1.4B
Revenue Per Share (ttm)14.95
Quarterly Revenue Growth (yoy)63.10%
Gross Profit (ttm)N/A
EBITDA -52.99M
Net Income Avi to Common (ttm)16.9M
Diluted EPS (ttm)0.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.39B
Total Cash Per Share (mrq)14.71
Total Debt (mrq)1.4B
Total Debt/Equity (mrq)145.20%
Current Ratio (mrq)4.05
Book Value Per Share (mrq)10.17

Cash Flow Statement

Operating Cash Flow (ttm)-533.67M
Levered Free Cash Flow (ttm)-366.59M